Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio (2010 - 2021)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Interest Coverage Ratio of 904.0 in Q2 2021, down 3175.36% quarter-over-quarter from 27.6 in Q4 2020.
Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio (2010 - 2021) Analysis & Trends
Sonoma Pharmaceuticals' Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 904.0 for Q2 2021.
- In Q2 2021, Interest Coverage Ratio changed N/A year-over-year to 904.0; the TTM figure through Mar 2022 stood at 5886.0 (down 1436.37% YoY), while the FY2021 annual figure was 287.42, up 37.77% from the prior year.
- Interest Coverage Ratio was 904.0 for Q2 2021 at Sonoma Pharmaceuticals, down from 27.6 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 42.25 in Q3 2020 to a low of 2912.0 in Q1 2017.
- Historically, Interest Coverage Ratio has averaged 602.75 across 5 years, with a median of 358.58 in 2017.
- The sharpest annual moves came in 2019 and 2020: Interest Coverage Ratio slumped 230.04% in 2019, then jumped 106.57% in 2020.
- A 5-year view of Interest Coverage Ratio shows it stood at 290.91 in 2017, then retreated by 15.4% to 335.71 in 2018, then tumbled by 230.04% to 1108.0 in 2019, then soared by 97.51% to 27.6 in 2020, then plunged by 3175.36% to 904.0 in 2021.
- The last three Interest Coverage Ratio figures came in at 904.0 (Q2 2021), 27.6 (Q4 2020), and 42.25 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -904.00 |
| Dec 31, 2020 | -27.60 |
| Sep 30, 2020 | 42.25 |
| Mar 31, 2020 | -1,074.67 |
| Dec 31, 2019 | -1,108.00 |
| Sep 30, 2019 | -643.50 |
| Jun 30, 2019 | -177.10 |
| Mar 31, 2019 | -386.29 |
| Dec 31, 2018 | -335.71 |
| Sep 30, 2018 | -378.86 |
| Jun 30, 2018 | -296.00 |
| Mar 31, 2018 | -527.67 |
| Dec 31, 2017 | -290.91 |
| Sep 30, 2017 | -285.70 |
| Jun 30, 2017 | -338.30 |
| Mar 31, 2017 | -2,912.00 |
| Sep 30, 2016 | -2,986.00 |
| Jun 30, 2016 | -3,509.00 |
| Mar 31, 2016 | -1,807.50 |
| Sep 30, 2015 | -1,858.00 |